Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127803792 | 12780379 | 2 | F | 20160919 | 20160926 | 20160927 | EXP | US-PFIZER INC-2989253 | PFIZER | NOY A.. AMC 048: MODIFIED CODOX-M/IVAC-RITUXIMAB IS SAFE AND EFFECTIVE FOR HIV-ASSOCIATED BURKITT LYMPHOMA. BLOOD. 2015;126(2):160-166 | 0.00 | Y | 0.00000 | 20160927 | OT | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127803792 | 12780379 | 1 | PS | CYTARABINE. | CYTARABINE | 1 | Intrathecal | 50 MG, CYCLIC, ON DAY 1 | 71868 | 50 | MG | ||||||||
| 127803792 | 12780379 | 2 | SS | METHOTREXATE SODIUM. | METHOTREXATE SODIUM | 1 | Intrathecal | 12 MG, CYCLIC, ON DAY 1 | 11719 | 12 | MG | ||||||||
| 127803792 | 12780379 | 3 | SS | METHOTREXATE SODIUM. | METHOTREXATE SODIUM | 1 | Intravenous drip | 3000 MG/M2, CYCLIC ON DAY 15 | 11719 | 3000 | MG/M**2 | ||||||||
| 127803792 | 12780379 | 4 | SS | DOXORUBICIN HCL | DOXORUBICIN HYDROCHLORIDE | 1 | Intravenous bolus | 50 MG/M2, CYCLIC ON DAY 1 | 63165 | 50 | MG/M**2 | SOLUTION FOR INJECTION | |||||||
| 127803792 | 12780379 | 5 | SS | LEUCOVORIN CALCIUM. | LEUCOVORIN CALCIUM | 1 | Intravenous drip | 200 MG/M2, CYCLIC | 0 | 200 | MG/M**2 | ||||||||
| 127803792 | 12780379 | 6 | SS | LEUCOVORIN CALCIUM. | LEUCOVORIN CALCIUM | 1 | Intravenous drip | 25 MG/M2, EVERY 6 HOURS | 0 | 25 | MG/M**2 | QID | |||||||
| 127803792 | 12780379 | 7 | SS | CYCLOPHOSPHAMIDE. | CYCLOPHOSPHAMIDE | 1 | Intravenous drip | 800 MG/M2, CYCLIC, ON DAYS 1-2 | 0 | 800 | MG/M**2 | ||||||||
| 127803792 | 12780379 | 8 | SS | PEGFILGRASTIM | PEGFILGRASTIM | 1 | 6 MG, CYCLIC, ON DAY 3 | 0 | 6 | MG | |||||||||
| 127803792 | 12780379 | 9 | SS | RITUXIMAB | RITUXIMAB | 1 | Intravenous drip | 375 MG/M2, CYCLIC, ON DAY 1 | 0 | 375 | MG/M**2 | ||||||||
| 127803792 | 12780379 | 10 | C | VINCRISTINE SULFATE. | VINCRISTINE SULFATE | 1 | Intravenous bolus | 1.40 MG/M2, CYCLIC, DAYS 1 AND 8 | 0 | 1.4 | MG/M**2 | ||||||||
| 127803792 | 12780379 | 11 | C | HYDROCORTISONE. | HYDROCORTISONE | 1 | 50 MG, UNK | 0 | 50 | MG |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127803792 | 12780379 | 1 | Burkitt's lymphoma |
| 127803792 | 12780379 | 2 | Burkitt's lymphoma |
| 127803792 | 12780379 | 4 | Burkitt's lymphoma |
| 127803792 | 12780379 | 5 | Burkitt's lymphoma |
| 127803792 | 12780379 | 7 | Burkitt's lymphoma |
| 127803792 | 12780379 | 8 | Burkitt's lymphoma |
| 127803792 | 12780379 | 9 | Burkitt's lymphoma |
| 127803792 | 12780379 | 10 | Burkitt's lymphoma |
| 127803792 | 12780379 | 11 | Arachnoiditis |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 127803792 | 12780379 | DE |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127803792 | 12780379 | Hepatic encephalopathy | |
| 127803792 | 12780379 | Hepatic failure | |
| 127803792 | 12780379 | Hepatitis B | |
| 127803792 | 12780379 | Pneumonia |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |